Crossmark

Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients—immune-related candidate proteins affected by TNF blocking treatment

Crossref DOI link: https://doi.org/10.1186/s13075-019-1846-6

Published Online: 2019-02-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Estelius, Johanna

Lengqvist, Johan

Ossipova, Elena

Idborg, Helena

Le Maître, Erwan

Andersson, Magnus L. A.

Brundin, Lou

Khademi, Mohsen

Svenungsson, Elisabet

Jakobsson, Per-Johan

Lampa, Jon
Funding

Funding for this research was provided by:

European Union Seventh Framework Programme (602919)

Vetenskapsrådet (2013-9306)

Reumatikerförbundet

Stockholms Läns Landsting

Wallenberg foundation
License Information

Text and Data Mining valid from 2019-02-15
More Information

Article History

Received: 30 July 2018

Accepted: 6 February 2019

First Online: 15 February 2019

Ethics approval and consent to participate

: The study was approved by the local ethics committee at Karolinska University Hospital, Stockholm, Sweden (numbers 01-371 and 2017/972-32). Written informed consent was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.